Clinical Trial

Linking Diet, Inflammation, Gut Microbiota, and Sarcopenia: A Cross-Sectional Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 7, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Based on the analysis of dietary characteristics, gut microbiota diversity, and composition, this study investigates the relationships between the dietary inflammatory potential, gut microbiota, and sarcopenia. Furthermore, it explores the mediating role of gut microbiota in the association between the dietary inflammatory index and the risk of sarcopenia. The findings are expected to provide insights into the mechanisms through which dietary inflammation influences the development and progression of sarcopenia, and to offer a basis for dietary and nutritional interventions aimed at preventing or managing this condition.
Trial Details
NCT Number NCT07211321
Lead Sponsor Jianhua Ma
Conditions Sarcopenia
Enrollment 1,220 participants
Start Date 2024-04-16
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-07